期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CHG和CAG预激方案治疗复发、难治性急性髓系白血病疗效的比较 被引量：27

原文传递
导出
摘要 日本学者Yamada等首先应用预激疗法治疗难治、复发性急性髓系白血病（AML），疗效显著，国内也有相应报道，但主要应用CAG方案，即小剂量阿糖胞苷（Ara-C）、阿克拉霉素（ACR）联合G-CSF。我们用高三尖杉酯碱（HHT）代替ACR组成CHG预激方案治疗难治、复发性AML，并对比观察了CHG和CAG方案的疗效，现将结果报告如下。
作者 魏旭东 刘艳艳 张丽娜 汪萍 张艳莉 朱兴虎 宋永平
机构地区 河南省肿瘤医院血液科
出处 《中华血液学杂志》 CAS CSCD 北大核心 2006年第1期64-64,共1页 Chinese Journal of Hematology
关键词 难治性急性髓系白血病 CAG方案 方案治疗 疗效显著 CHG 复发性 预激 高三尖杉酯碱(HHT) 小剂量阿糖胞苷 G-CSF
分类号 R733.71 [医药卫生—肿瘤] R521 [医药卫生—内科学]
  • 相关文献

参考文献3

二级参考文献13

  • 1全国白血病化学治疗讨论会.急性白血病疗效标准[J].中华血液学杂志,1988,9(3):183-183.
  • 2Hiddemann W, Martin WR, Sauerland CM,et al. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubiein (TAD 9) in 150 patients with relapse after standardized first line therapy.Leukemia, 1990, 4: 184-188.
  • 3Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aelarubiein for previously treated acute myelngenous leukemia: a pilot study. Leukemia, 1995, 9: 10-14.
  • 4Saito K, Nakamura Y, Aoyagi M, et al. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML)and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation. Int J Hematol, 2000. 71: 238-244.
  • 5Park LS, Waldron PE, Friend D, et al. Interleukin-3, GM-CSF and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood, 1989, 74: 56-65.
  • 6Wormann B, Reuter C, Zuhlsdorf M, et al. Experimental basis for the use of recombinant human granulocyte-maerophage colonystimulating factor in patients with acute myeloid leukemia. Semin Oncol, 1994, 21(6 suppl 16) : 39-43.
  • 7Bai A, Kojima H, Hori M, et al. Priming with G-CSF effectively enhances low-dose Ara-C-indueed in vivo apoptosis in myeloid leukemia cells. Exp Hematol, 1999, 27: 259-265.
  • 8Katagiri T, Miyazawa K, Nishimaki J, et al. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro. Leuk Lymphoma, 2000, 39: 173-184.
  • 9Hasegawa Y, Bai A, Kojima H, et al. Priming effects of macrophage colony-stimulating factor on monocytic leukemia cells in combination with chemotherapy: induction of programmed cell death in vivo. Leuk Lymphoma, 2000, 36: 589-593.
  • 10Akashi K, Eto T, Shibuya T, et al. Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony-stimulating factor. Leuk Res,2000, 24:243-248.

共引文献42

同被引文献197

引证文献27

二级引证文献68

中华血液学杂志
2006年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部